Published in Gene Therapy Weekly, April 23rd, 2009
"There were no OZ1-related adverse events. There was no statistically significant difference in viral load between the OZ1 and placebo group at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly